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Aim. Planar myocardial 123I-meta-iodobenzylguanidine (123I-mIBG) scintigraphy is a
highly reproducible technique. However, differences in collimator use are one of the most
important factors that cause variation among institutions and studies in heart-to-mediastinum
(H/M) ratio. Therefore, standardization among various gamma camera-collimator combina-
tions is needed. Previously, a phantom has been developed to cross-calibrate different
acquisition conditions in Japan. For further cross-calibration of European myocardial 123I-
mIBG imaging, the aim of this study was to collect 123I-mIBG data for H/M ratios from
common European gamma camera vendors.
Methods. 210 experiments were performed in 27 European institutions. Based on these
experiments, conversion coefficients for each gamma camera-collimator combination were
calculated. An averaged conversion coefficient of 0.88 was used to calculate a standardized H/M
ratio.
Results. On average, LE-collimator-derived H/M ratios were significantly lower compared
to ME-collimator-derived H/M ratios. The mean conversion coefficients ranged from 0.553 to
0.605 for the LE-collimator group and from 0.824 to 0.895 for the ME-collimator group.
Conclusion. Clinically established H/M ratios can be converted into standardized H/M
ratios using cross-calibrated conversion coefficients. This standardization is important for
identifying appropriate thresholds for adequate risk stratification. In addition, this cross-cali-
bration enables comparison between different national and international data. (J Nucl Cardiol
2017)
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H/M ratio Heart-to-mediastinum ratio
LE Low energy
LEAP Low energy all-purpose
LEHR Low energy high resolution
LMEGP Low-medium-energy general purpose
ME Medium energy
MEGP Medium energy general purpose
MELP Medium energy low penetration
WO Washout
INTRODUCTION
Cardiac 123I-mIBG scintigraphy, a non-invasive
imaging technique to assess cardiac sympathetic activ-
ity, has been shown to be of clinical value, especially for
the assessment of prognosis, in many cardiac dis-
eases.1–5 The quantification method is essential to
differentiate normal and abnormal cardiac sympathetic
activity and to distinguish high- and low-risk groups.
The heart-to-mediastinum (H/M) ratio is a simple
method to correct for background and is highly repro-
ducible with small inter- and intra-observer variation.6
However, standardization of acquisition and analysis is
needed. The lack of standardization between different
institutions is one of the factors that have hampered
wide scale clinical implementation of cardiac 123I-mIBG
scintigraphy. International efforts have been made to
harmonize and standardize cardiac 123I-mIBG scintigra-
phy.7 These recommendations include proposals for
patient preparation, administered dose of 123I-mIBG
activity (MBq), scanning parameters, and analysis of the
acquired data to obtain the most used semi-quantitative
parameters [i.e., early and late H/M ratio and 123I-mIBG
washout (WO)].
Collimator choice is one of the most important
factors causing variation among institutions and stud-
ies.8,9 In addition to 159 keV photons, 123I emits high-
energy photons of 529 keV which penetrate the rela-
tively thin septa of low-energy (LE) collimators. This
penetration leads to degradation of image quality and
ultimately introduces variation in H/M ratios.10 Med-
ium-energy (ME) collimators have thicker septa and
lower photon penetration compared to LE collimators
and therefore have improved image quality and accuracy
in myocardial 123I-mIBG imaging, however, at the
expense of spatial resolution.11–13 Consequently, the
use of ME collimators is recommended for estimation
the H/M ratios.7 However, LE collimators are still
commonly applied for cardiac 123I-mIBG scintigraphy
because of their wide availability.7 In addition, although
the nomenclature of collimators is classified into 2 major
groups of LE and ME collimators, various types of
collimators have been developed depending on the
clinical purpose. The variety in the collimator types used
has hampered multicentre comparison of cardiac 123I-
mIBG scintigraphy-derived parameters and single-centre
results could not easily be extrapolated to other
institutions.14
In Japan, a phantom for planar cardiac 123I-mIBG
imaging has been developed to cross-calibrate different
acquisition conditions.15 This phantom has been used to
calculate conversion coefficients for different gamma
camera-collimator combinations in Japan.16 With these
conversion coefficients, various conditions can be con-
verted to standard H/M ratios. As an extension of this
phantom study, the purpose of this study was to accumu-
late H/M ratios from common gamma camera vendors in
Europe and compare these data with the data from Japan.
METHODS
Phantom Design and Experiment
A light-weight calibration phantom was used as previously
described.17 111 MBq 123I was mixed with 4450 ml water to fill
the phantom. Since all organ parts were connected as one
compartment, no radionuclide concentration adjustment was
required for each organ separately. A 3 cm acrylic plate was
placed over the phantom to simulate human body attenuation,
when imaging was performed. The 256 9 256 matrix images
were acquired from the anterior and posterior views for
5 minutes, comparable to clinical planar cardiac 123I-mIBG
imaging (Figure 1). The energy window was centered at 159
keV with a 15% window. The phantom was placed centrally
under the gamma camera head with a 5 cm distance between the
phantom and collimator surface. The experiments were per-
formed using 210 conditions in 27 institutions in Europe (see
‘‘Appendix’’ for list of all participating institutions).
Mathematical Reference Value of H/M
Ratio
All 123I-mIBG phantom images were acquired in each
participating institution. Data were anonymized and were sent
to the Kanazawa University in Japan for central analysis. H/M
ratios were mathematically calculated, assuming a linear
attenuation coefficient (l) of 123I for water as 0.147 cm-1.
The standard equation for attenuation was used (i.e., exponen-
tial of -lx, where x stands for the thickness of the attenuating
material). The mathematical calculated reference H/M ratio
was corrected for attenuation, while Compton scatter and
septal penetration of gamma rays were not included. The
reference H/M ratios determined by the structure of the
phantom were 2.60 and 3.50 (respectively, anterior and
posterior acquisition). Instead of the original phantom used
in the Japanese studies, a new light-weight phantom was used
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in the European study. In the latter phantom, although the
dimensions of the phantom were identical, some acrylic parts
were made hollow to fill with non-radioactive water. To obtain
identical results compared to the original phantom, minor
differences in reference values derived from the light-weight
phantom were adjusted. The phantom dimensions of the
original light-weighted phantom type were measured by CT
scan, and the attenuation in the water and acrylics was
recalculated. The adjustment of minor difference of phantom
design using linear regression line resulted in agreement of
conversion coefficients using low energy high resolution
(LEHR), low-medium-energy general purpose (LMEGP), and
medium energy general purpose (MEGP) collimators.
Cross Calibration
In this study, two H/M ratios (anterior and posterior
acquisitions) from each institution were plotted against the
reference values (Figure 2). A linear regression equation was
calculated using the formula:
y  1 ¼ K  x  1ð Þ
(* denotes multiplication), in which the line always passes on the
coordinate (1, 1). The coefficient Ki (i.e., slope of the regression
line for each institution) was used to convert the institutional H/
M ratios to the reference values (H/M ratioref). In the second step,
the H/M ratioref was converted to a standardized H/M ratio using
the Kstd. This process can be summarized as:
Standardized H=M ratio  1
¼ Kstd=Ki  institutional H=M ratio  1ð Þ:
The Kstd was 0.88, defined as the average K values for typical
ME collimators. The rationale for this conversion to the
common ME-collimator type is based on the recommendation
to use ME collimators.
STATISTICS
The data are shown as mean ± standard deviation.
Differences among groups were examined by one-way
analysis of variance and Student’s t test. The linear
regression equation of the H/M ratios between two
conditions was calculated by the least square method.
The statistics software JMP (version 11, SAS Institute
Inc., Cary, NC, USA) was used and mathematical
calculation was based on Mathematica 10 (Wolfram
Research Inc., Champaign, IL, USA).
RESULTS
210 123I-mIBG phantom studies were performed in
27 institutions in Austria, Belgium, the Netherlands, and
the United Kingdom including camera vendors of
Siemens (n = 148), GE (n = 44) and Philips (n = 18).
Collimator types were divided into 2 groups: LE and
ME. The LE group included LEHR, general purpose
(LEGP), and all-purpose (LEAP) collimators. The ME
group included LMEGP, MEGP, and low-penetration
(MELP) collimators.
H/M Ratio Measured in Two Phantom
Conditions
Overall, the LE-collimator group showed lower H/
M ratios compared with the ME-collimator group. For
Figure 1. Example of planar 123I-mIBG images of the phan-
tom in anterior (left panels) and posterior (right panels) view
with Symbia system (Siemens, Erlangen, Germany). Note the
difference in image quality due to septal penetration or scatter
between low-energy and medium-energy collimators. LEHR
low energy high resolution; MELP medium energy low
penetration.
Figure 2. Conversion of H/M ratio from an institutional
condition A (H/M ratioA) to the standard value (H/M
ratiostandard). The slope of the regression line of the institutional
condition, coefficient Ki, and the averaged coefficient of
common ME collimators, coefficient Kstd = 0.88, allows for the
calculation of a conversion coefficient corrected to a common
ME-collimator type.
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the phantom H/M ratio of 2.60, the LE-collimator (n =
113)- and ME-collimator (n = 97)-derived H/M ratios
were 1.932 ± 0.056 and 2.685 ± 0.088, respectively, (p
= \0.0001). Similarly, for the phantom H/M ratio of
3.50, the LE-collimator- and ME-collimator- derived H/
M ratios were 2.281 ± 0.074 and 3.354 ± 0.124,
respectively, (p\ 0.0001) (Figure 3).
Conversion Coefficients Determined by 2
Data Points
The conversion coefficients to the reference value
are summarized according to the main collimator names:
3 LE sub-groups and 3 ME sub-groups. (Table 1) The
average conversion coefficients were 0.553 for LEHR,
0.605 for LEAP, 0.570 for LEGP, 0.824 for LMEGP,
and 0.882 for MEGP, and the highest was 0.895 for
MELP types. When the conversion coefficients were
divided into a LE and a ME group, the average values
were, respectively, 0.556 ± 0.021 and 0.880 ± 0.036
(p\ 0.0001) (Figure 4). Figure 5 shows conversion
coefficients of the most common used LE- and ME-
collimator types per vendor.
Comparison Between European and
Japanese Conversion Coefficients
Overall, there were no significant differences when
the European conversion coefficients of LEHR, LEAP,
LMEGP, and MEGP collimators were compared with
the Japanese conversion coefficients (Table 1). Only the
conversion coefficients for LEGP and MELP collimators
differed significantly (p\ 0.0001). However, when the
conversion coefficients for MEGP and MELP were
combined, the difference was no longer statistically
significant. In contrast when the conversion coefficients
for LEGP and LEAP were combined, the statistical
significant difference persisted between the European
and Japanese data.
DISCUSSION
These are the results of the first European myocar-
dial 123I-mIBG cross-calibration phantom study to
calculate conversion coefficients for specific individual
gamma camera-collimator combinations. The cross-cal-
ibration allowed for a conversion of institutional H/M
ratios to standardized H/M ratios. These conversion
coefficients will facilitate multicentre comparison of
myocardial 123I-mIBG results and enable the extrapola-
tion of the outcome of single- and multicentre studies to
other institutions.
The design of collimator septa and apertures has
influence on the septal penetration. ME collimators, as
recommend by the EANM Cardiovascular Committee,7
have thicker septa and lower penetration compared to
LE collimators. The difference in collimator types is
therefore one of the most important factors that affect
variation in H/M ratios. It has been shown that H/M
ratios derived from LE collimators are significantly
lower compared to those from ME collimators.8,17 This
has been confirmed by the previous cross-calibration
phantom study in Japan showing significant underesti-
mation of H/M ratios derived from LE collimators.16 As
H/M ratios help differentiating high-risk and low-risk
groups, this could have clinical implications. However,
after correction to standardized H/M ratios, LE and ME
collimators showed comparable values.16
The present study shows that the conversion coef-
ficients of the LE collimators are lower compared to the
ME collimators which is in line with previous phantom
studies in Japan (Table 1). The conversion coefficients
for most LE- and ME-collimator sub-groups did not
show any statistical differences between Europe and
Figure 3. Individual data points and box-whisker plots of H/
M ratios using phantoms with the reference H/M ratio of 2.60
(panel A) and 3.50 (panel B). Green lines denote mean values.
The box plot shows median and the 1st and 3rd quartile, and
the ends of the whiskers are ± 1.5 *(interquartile range).
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Japan. However, there was a significant difference in the
LEGP and MELP sub-group.
There are several factors that could explain varia-
tion in the LEGP and MELP sub-group between the
European and Japanese institutions. Most likely, the
small number of LEGP and MELP collimators may have
resulted in a limited statistical power. In addition, these
differences may be explained by small differences in the
phantom used. In contrast to the original designed
phantom used in Japan, a light-weight phantom was
used for the current European study. After careful
examination of both cross-calibration phantoms by CT
scanner (Symbia T6/16, Siemens. Erlangen, Germany),
under the same conditions (120 mAs and 130 kV), there
was a small difference of \1 mm of the 123I-mIBG
compartment between the conventional and light-weight
types. Furthermore, one could expect minor differences
between Japanese and European camera combinations
due to differences in the design of the collimator septa
and apertures and gamma camera crystals. However, we
have confirmed with the manufacturers that both colli-
mators and gamma cameras used are manufactured
identical for Europe and Japan. The differences between
LEAP and MELP may also be explained by small
variations in acquisition. In Europe and Japan, both
energy windows of 15% and 20% have been used
according to local protocol. The acquisition time ranged
from 3 to 10 minutes in Japan and was 5 minutes in
Europe. The distance from collimator to phantom was
the same in Europe and Japan. Moreover, although 123I
was manufactured by different companies in Japan
(FUJIFILM RI Pharma, Tokyo, Japan) and Europe (GE
Healthcare, Eindhoven, The Netherlands), both products
showed no contamination of other isotopes. Finally,
there might be a difference between used acrylics of the
original phantom and water in some compartments of
the light-weight phantom. Although both water and the
used acrylics have an almost identical decay coefficient
with a very similar scatter pattern, this minor difference
in phantom design may explain the found differences in
coefficient values. In summary although there is no
variation between Europe and Japan for most LE and
ME groups, there is a minimal difference in the LEAP
and MELP collimator group. As shown, there is a
variety of possible explanations for this small difference.
However, except for the relative small number of
experiments, the above mentioned factors are true for
all comparisons between the European and Japanese
data. Hence, if valid, these factors would have caused
also differences between the other collimators groups.
Table 1. Conversion coefficient of collimators: European vs. Japanese studies
Europe Japan*
P values between
Europe and JapanN Mean SD N Mean SD
LEHR 103 0.553 0.018 73 0.552 0.048 0.85
LEGP?LEAP group** 10 0.591 0.024 25 0.648 0.036 \0.0001
LEGP 4 0.570 0.011 17 0.654 0.037 0.0003
LEAP 6 0.605 0.020 2 0.624 0.014 0.15
LMEGP 16 0.824 0.035 46 0.829 0.055 0.74
MEGP?MELP group 81 0.891 0.025 53 0.895 0.061 0.60
MEGP*** 28 0.882 0.017 40 0.878 0.054 0.71
MELP 53 0.895 0.027 13 0.950 0.051 \0.0001
*Data from J Nucl Cardiol 2014; 21: 970–978
**LE general-all-purpose collimator is included in Japanese study
*** MEGP, ME general-all purpose, and ME collimators are included in Japanese study
Figure 4. Conversion coefficients to the reference values for
the LE- and ME-collimator groups. Data points and box-
whisker plots are also shown. Green lines denote mean values.
The box plot shows median and the 1st and 3rd quartile, and
the ends of the whiskers are ± 1.5 *(interquartile range).
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Therefore, this difference is most likely driven for the
largest part by the relative small number of experiments.
Of course variation in phantom design, variation in
energy windows, and variation in acquisition time may
have also contributed.
Our study has some limitations. Compared to the
Japanese cross-calibration study, we only used 2 (2.60
and 3.50) instead of 4 (1.35, 1.80, 2.60, and 3.50)
references H/M ratios. However, conversion coefficients
from 2 data points were nearly identical to those 4 data
points.16 In addition, this cross-calibration method only
corrects for high-energy photons coming from liver and
lungs, which are the most important contributors of
counts overestimation in the mediastinum and heart.8
However, this method does not correct for high-energy
photons coming other organs like kidney and bladder. In
addition, it is important to realize that phantom data are
only an approximation of the clinical setting. Therefore,
the validity of the conversion coefficients is not
guaranteed.
In conclusion, differences in gamma camera-colli-
mator combinations can be corrected to standardize ME-
collimator values with the use of a cross-calibration
phantom. This method can readily be applied, reducing
variation in outcome measures and thereby further the
clinical role of myocardial 123I-mIBG scintigraphy.
NEW KNOWLEDGE GAINED
Standardization of H/M ratios has impact on patient
management. Most importantly, standardization of H/M
ratio allows for the development of a universal prog-
nostic threshold. This could be established by
reanalyzing databases from a number of 123I-mIBG
studies previously published. In addition, future multi-
centre studies should aim for the use of a standardized
H/M ratio, overcoming the impact of gamma camera and
collimator differences. Finally, to further stress the
importance of standardized H/M ratios, standardized
values are essential in risk models for cardiac
mortality.18
Funding
This study was funded by a research Grant from GE
healthcare B.V. (Grant number ADR-14-03).
Disclosure
K. Nakajima, MD, PhD, has a collaboration to develop
software with FUJIFILM RI Pharma, Co. Ltd, Tokyo, Japan.
All other authors (D.O. Verschure, E. Poel, K. Okuda, B.L.F.
van Eck-Smit, G.A.Somsen, H.J. Verberne) declare that he/she
has no conflict of interest.
Open Access
This article is distributed under the terms of the Creative
Commons Attribution 4.0 International License (
http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any med-
ium, provided you give appropriate credit to the original au-
thor(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made.
APPENDIX
Participating institutions included (alphabetical
order):
Academic Medical Center (Amsterdam, the
Netherlands),
Amphia ziekenhuis (Breda, the Netherlands),
AZ Groeninge (Kortijk, Belgium),
AZ Maria Middelares (Gent, Belgium),
AZ Sint Jan (Brugge, Belgium),
Diakonessenhuis (Utrecht, the Netherlands),
Erasmus Medical Center (Rotterdam, the Netherlands),
Gelderse Vallei (Ede, the Netherlands),
Figure 5. Conversion coefficients of the most common used
LE- and ME-collimator types per vendor. Green lines denote
mean values. The box plot shows median and the 1st and 3rd
quartile, and the ends of the whiskers are ± 1.5 *(interquartile
range).
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Groene Hart ziekenhuis (Gouda, the Netherlands),
Jeroen Bosch Ziekenhuis (Den Bosch, the Netherlands),
Leids University Medical Center (Leiden, the
Netherlands),
Medical Center Leeuwarden (Leeuwarden, the
Netherlands),
Onze Lieve Vrouw (Aalst, Belgium),
OLVG oost (Amsterdam, the Netherlands),
OLVG west (Amsterdam, the Netherlands),
Noordwest ziekenhuisgroep (Alkmaar, the Netherlands),
Sint Augustinus (Wilrijk, Belgium),
Spaarne Gasthuis (Hoofddorp, the Netherlands),
Spaarne Gasthuis (Haarlem, the Netherlands),
University Hospital of North Durham (Durham, United
Kingdom),
University Medical Center Groningen (Groningen, the
Netherlands),
University Medical Center Utrecht (Utrecht, the
Netherlands),
UZ Antwerpen (Edegem, Belgium),
UZ Brussel (Brussel, Belgium),
UZ Leuven (Leuven, Belgium)
Wilhelminenspital (Vienna, Austria),
Zuyderland Medical Center (Heerlen, the Netherlands)
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